Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Sell
40
STXS Quote, Financials, Valuation and Earnings
Last price:
$2.34
Seasonality move
:
7.3%
Day range:
$2.28 - $2.35
52-week range:
$1.66 - $3.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.83x
P/B ratio:
18.33x
Volume:
109.4K
Avg. volume:
459.2K
1-year change:
27.17%
Market cap:
$198.3M
Revenue:
$26.8M
EPS (TTM):
-$0.27
Analysts' Opinion
-
Consensus RatingStereotaxis has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Stereotaxis has an estimated upside of 92.31% from its current price of $2.34.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $2.34.
Fair Value
-
According to the consensus of 0 analysts, Stereotaxis has 92.31% upside to fair value with a price target of -- per share.
STXS vs. S&P 500
-
Over the past 5 trading days, Stereotaxis has underperformed the S&P 500 by -4.09% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Stereotaxis does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Stereotaxis has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Stereotaxis reported revenues of $9.2M.
Earnings Growth
-
Stereotaxis has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Stereotaxis reported earnings per share of -$0.08.
Enterprise value:
193M
EV / Invested capital:
11.90x
Price / LTM sales:
7.83x
EV / EBIT:
--
EV / Revenue:
7.68x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-15.78x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$14.1M
Return On Assets:
-50.67%
Net Income Margin (TTM):
-85.79%
Return On Equity:
-108.68%
Return On Invested Capital:
-108.68%
Operating Margin:
-69%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $29.1M | $29.5M | $25.1M | $7.8M | $9.2M | |
| Gross Profit | $20.1M | $16.4M | $14.1M | $4.1M | $4.1M | |
| Operating Income | -$17.7M | -$21M | -$22.4M | -$5.6M | -$6.3M | |
| EBITDA | -$17.3M | -$20.4M | -$21.7M | -$5.5M | -$6M | |
| Diluted EPS | -$0.25 | -$0.27 | -$0.27 | -$0.07 | -$0.08 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $53.9M | $53.4M | $46.1M | $35.5M | $28.8M | |
| Total Assets | $57.1M | $61.9M | $56.1M | $44.5M | $50.9M | |
| Current Liabilities | $13.4M | $13.8M | $15.6M | $13M | $20.7M | |
| Total Liabilities | $16.5M | $21.8M | $22.7M | $20.2M | $34.7M | |
| Total Equity | $40.6M | $40.2M | $33.4M | $24.3M | $16.2M | |
| Total Debt | $2.2M | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$7.1M | -$9.3M | -$12.2M | -$967K | -$4.3M | |
| Cash From Investing | -$3.2M | -$320K | $76K | -$10K | $98K | |
| Cash From Financing | $170K | $116K | $164K | $25K | $80K | |
| Free Cash Flow | -$10.3M | -$10M | -$12.2M | -$977K | -$4.3M | |
STXS
Sector
Market Cap
$198.3M
$46.1M
Price % of 52-Week High
71.13%
46.02%
Dividend Yield
0%
0%
Shareholder Yield
-0.1%
-0.6%
1-Year Price Total Return
27.17%
-30.52%
Beta (5-Year)
1.570
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$2.33
200-day SMA
Buy
Level
$2.14
Bollinger Bands (100)
Buy
Level
1.9 - 2.24
Chaikin Money Flow
Sell
Level
-128.3M
20-day SMA
Buy
Level
$2.28
Relative Strength Index (RSI14)
Buy
Level
56.46
ADX Line
Buy
Level
17.01
Williams %R
Neutral
Level
-34.7368
50-day SMA
Buy
Level
$2.10
MACD (12, 26)
Buy
Level
0.06
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Neutral
Level
40.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-14.0498)
Sell
CA Score
(Annual)
Level (-2.0124)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (3.9832)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.
Stock Forecast FAQ
In the current month, STXS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The STXS average analyst price target in the past 3 months is --.
-
Where Will Stereotaxis Stock Be In 1 Year?
According to analysts, the consensus estimate is that Stereotaxis share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Stereotaxis?
Analysts are divided on their view about Stereotaxis share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Stereotaxis is a Sell and believe this share price will drop from its current level to --.
-
What Is Stereotaxis's Price Target?
The price target for Stereotaxis over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is STXS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Stereotaxis is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of STXS?
You can purchase shares of Stereotaxis via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Stereotaxis shares.
-
What Is The Stereotaxis Share Price Today?
Stereotaxis was last trading at $2.34 per share. This represents the most recent stock quote for Stereotaxis. Yesterday, Stereotaxis closed at $2.34 per share.
-
How To Buy Stereotaxis Stock Online?
In order to purchase Stereotaxis stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
